TABLE 5.
Confidence on the diagnosis (0–10, from not confidence at all to very confident) | Statistics | |||||
(Q3) Confidence on the diagnosis of major depressive disorder based on symptoms# | N | Mean | SD | Median | Min | Max |
14 | 5.50 | 2.31 | 5.5 | 1 | 9 | |
(Q4) Willingness to take medication for symptoms* | N | Mean | SD | Median | Min | Max |
14 | 5.50 | 2.31 | 5.5 | 1 | 9 | |
(Q28) Confidence on the diagnosis of non-solid brain tumor based on symptoms# | N | Mean | SD | Median | Min | Max |
13 | 1.62 | 2.33 | 1 | 0 | 7 | |
(Q29) Willingness to take medication for symptoms* | N | Mean | SD | Median | Min | Max |
13 | 3.38 | 3.52 | 2 | 0 | 9 | |
(Q30) Confidence on the diagnosis of mental illnesses in the end of the survey∧ | N | Mean | SD | Median | Min | Max |
13 | 3.92 | 2.72 | 5 | 0 | 8 |
#p < 0.001, based on the Wilcoxon rank sum test.
*p = 0.1, based on the Wilcoxon rank sum test. The medications were assumed to have the same efficacy to treat symptoms of the diagnoses: 40–60% effectiveness for patients, while placebo worked for 20% to 40% of the patients (17).
∧p = 0.16, compared with the confidence in the diagnosis of major depressive disorder based on symptoms (Q3) using the Wilcoxon rank sum test. SD, standard deviation.